CDEX's ID2 Meth Scanner to help combat the growing problem of methamphetamine use

CDEX Inc. (OTCBB: CEXI) announces completion of development-phase testing of a new generation Meth Scanner™ that embodies cell-phone technology and multi-filter applications. The new generation Scanner will have a cell-phone-interactive readout that increases functionality to provide more options for the law enforcement community in its battle against methamphetamine use. In addition, the technological advancements of multi-filter integration will provide greater sensitivity and a platform for multi-drug applications for the Scanner. The ID2 Meth Scanner LE (Law Enforcement) is currently being distributed by Decatur Electronics to national Law Enforcement markets. Decatur Electronics, headquartered in Decatur, Illinois, is also a leading manufacturer of radar speed detectors and in-car video surveillance equipment for law enforcement applications.

The August issue of the Law Enforcement Technology Magazine provides a report on the progress of the ID2 Meth Scanner. While the article features law enforcement applications, it also references the ID2 Meth Scanner PI (Property Inspection Model) in the context of field testing at a county public health department in Washington State of a Meth Scanner (PI) modified to meet the more restrictive Washington State methamphetamine remediation standards. The results of those and follow up tests will be very helpful in further understanding the limits of the Scanner PI Model's sensitivity.

"The ID2 Meth Scanner is a revolutionary product that provides the law enforcement community with a new tool to help combat the growing problem of methamphetamine use," said Tim Shriver, CDEX COO. "The ID2 Meth Scanner is rapidly evolving, with the help of government agencies such as the county public health department in Washington State, to meet the requirements of both law enforcement and property inspection applications. The Law Enforcement Technology Magazine article provides insight into our improvement process and the culture of our company."

Source:

CDEX Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers discover how mutations disrupt protein splicing and cause disease